中国儿童代谢健康型肥胖定义与筛查专家共识

2019-12-30 中国儿科相关医学专家组(统称) 中国妇幼健康研究.2019.30(12):1489-1490.

儿童青少年肥胖发病率不断升高,但并非所有相同程度肥胖的个体都具有相同的心血管代谢风险,故根据代谢风险定义中国儿童青少年代谢健康型肥胖(MHO)表型,并筛查代谢异常型肥胖(MUO)对儿童青少年肥胖的临床管理和治疗决策具有重要意义。由此召集并成立了一个由多名多学科专家组成的委员会,基于国内大型儿童青少年代谢综合征前瞻性队列研究结果,参考国外相关研究结论,形成了一个中国儿童MHO定义。MHO的定义包括:

中文标题:

中国儿童代谢健康型肥胖定义与筛查专家共识

发布日期:

2019-12-30

简要介绍:

儿童青少年肥胖发病率不断升高,但并非所有相同程度肥胖的个体都具有相同的心血管代谢风险,故根据代谢风险定义中国儿童青少年代谢健康型肥胖(MHO)表型,并筛查代谢异常型肥胖(MUO)对儿童青少年肥胖的临床管理和治疗决策具有重要意义。由此召集并成立了一个由多名多学科专家组成的委员会,基于国内大型儿童青少年代谢综合征前瞻性队列研究结果,参考国外相关研究结论,形成了一个中国儿童MHO定义。MHO的定义包括:依据体质量指数(BMI)诊断肥胖:BMI≥95百分位数(同年龄同性别,适用年龄≥2岁),同时高密度脂蛋白胆固醇>1.03mmol/L、甘油三酯<1.70mmol/L、收缩压和舒张压<同年龄同性别儿童血压的第90百分位数(P90)及空腹血糖<5.6mmol/L。专家委员会进一步制定出筛查MUO的共识。

 

拓展指南:肥胖相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国儿童代谢健康型肥胖定义与筛查专家共识)] GetToolGuiderByIdResponse(projectId=1, id=55e7e1c001853369, title=中国儿童代谢健康型肥胖定义与筛查专家共识, enTitle=, guiderFrom=中国妇幼健康研究.2019.30(12):1489-1490., authorId=null, author=, summary=儿童青少年肥胖发病率不断升高,但并非所有相同程度肥胖的个体都具有相同的心血管代谢风险,故根据代谢风险定义中国儿童青少年代谢健康型肥胖(MHO)表型,并筛查代谢异常型肥胖(MUO)对儿童青少年肥胖的临床管理和治疗决策具有重要意义。由此召集并成立了一个由多名多学科专家组成的委员会,基于国内大型儿童青少年代谢综合征前瞻性队列研究结果,参考国外相关研究结论,形成了一个中国儿童MHO定义。MHO的定义包括:, cover=, journalId=null, articlesId=null, associationId=924, associationName=中国儿科相关医学专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Dec 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>儿童青少年肥胖发病率不断升高,但并非所有相同程度肥胖的个体都具有相同的心血管代谢风险,故根据代谢风险定义中国儿童青少年代谢健康型肥胖(MHO)表型,并筛查代谢异常型肥胖(MUO)对儿童青少年肥胖的临床管理和治疗决策具有重要意义。由此召集并成立了一个由多名多学科专家组成的委员会,基于国内大型儿童青少年代谢综合征前瞻性队列研究结果,参考国外相关研究结论,形成了一个中国儿童MHO定义。MHO的定义包括:依据体质量指数(BMI)诊断肥胖:BMI≥95百分位数(同年龄同性别,适用年龄≥2岁),同时高密度脂蛋白胆固醇>1.03mmol/L、甘油三酯<1.70mmol/L、收缩压和舒张压<同年龄同性别儿童血压的第90百分位数(P90)及空腹血糖<5.6mmol/L。专家委员会进一步制定出筛查MUO的共识。 </P> <P> </P>拓展指南:<strong>与<font color=red>肥胖</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=986551c0018511d0" title="2020 ESE临床实践指南:肥胖的内分泌检查" target=_blank>2020 ESE临床实践指南:肥胖的内分泌检查</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b0d7d1c001e987f1" title="2019 年《欧洲实践指南:初级医疗中成年人肥胖的管理》解读" target=_blank>2019 年《欧洲实践指南:初级医疗中成年人肥胖的管理》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4aa991c001e795f9" title="2016 ISTH指南:使用直接口服抗凝剂治疗肥胖患者" target=_blank>2016 ISTH指南:使用直接口服抗凝剂治疗肥胖患者</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f456f1c001e788f1" title="2019 BTS临床实践指南:肥胖低通气综合征的评估和管理" target=_blank>2019 BTS临床实践指南:肥胖低通气综合征的评估和管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a58fb1c001e20217" title="2019 HFSA共识声明:心衰患者的营养,肥胖和恶病质" target=_blank>2019 HFSA共识声明:心衰患者的营养,肥胖和恶病质</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%A5%E8%83%96" target=_blank>有关肥胖更多指南</a></ul>, tagList=[TagDto(tagId=99039, tagName=儿童代谢健康型肥胖)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3842, appHits=253, showAppHits=11, pcHits=2124, showPcHits=2523, likes=59, shares=17, comments=6, approvalStatus=1, publishedTime=Sat Jan 25 20:36:32 CST 2020, publishedTimeString=2019-12-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 25 20:36:32 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 12:24:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国儿童代谢健康型肥胖定义与筛查专家共识)])
中国儿童代谢健康型肥胖定义与筛查专家共识
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=969819, encodeId=eace969819c7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d4d2579432, createdName=1259f56bm76暂无昵称, createdTime=Mon May 31 11:19:44 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917351, encodeId=200a91e3510b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883577, encodeId=8fab8835e7ec, content=洪客隆, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:50:59 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2021-05-31 1259f56bm76暂无昵称

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=969819, encodeId=eace969819c7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d4d2579432, createdName=1259f56bm76暂无昵称, createdTime=Mon May 31 11:19:44 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917351, encodeId=200a91e3510b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883577, encodeId=8fab8835e7ec, content=洪客隆, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:50:59 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2021-01-17 黄伟医生

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=969819, encodeId=eace969819c7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d4d2579432, createdName=1259f56bm76暂无昵称, createdTime=Mon May 31 11:19:44 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917351, encodeId=200a91e3510b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:07 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883577, encodeId=8fab8835e7ec, content=洪客隆, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:50:59 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2020-09-08 ms1000000302953060

    洪客隆

    0